<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25360749</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling.</ArticleTitle><Pagination><StartPage>e111496</StartPage><MedlinePgn>e111496</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e111496</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0111496</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) causes seasonal epidemics of hand-foot-and-mouth disease and has a high mortality rate among young children. We recently demonstrated potent induction of the humoral and cell-mediated immune response in monkeys immunized with EV71 virus-like particles (VLPs), with a morphology resembling that of infectious EV71 virions but not containing a viral genome, which could potentially be safe as a vaccine for EV71. To elucidate the mechanisms through which EV71 VLPs induce cell-mediated immunity, we studied the immunomodulatory effects of EV71 VLPs on human monocyte-derived dendritic cells (DCs), which bind to and incorporate EV71 VLPs. DC treatment with EV71 VLPs enhanced the expression of CD80, CD86, CD83, CD40, CD54, and HLA-DR on the cell surface; increased the production of interleukin (IL)-12 p40, IL-12 p70, and IL-10 by DCs; and suppressed the capacity of DCs for endocytosis. Treatment with EV71 VLPs also enhanced the ability of DCs to stimulate na&#xef;ve T cells and induced secretion of interferon (IFN)-&#x3b3; by T cells and Th1 cell responses. Neutralization with antibodies against Toll-like receptor (TLR) 4 suppressed the capacity of EV71 VLPs to induce the production of IL-12 p40, IL-12 p70, and IL-10 by DCs and inhibited EV71 VLPs binding to DCs. Our study findings clarified the important role for TLR4 signaling in DCs in response to EV71 VLPs and showed that EV71 VLPs induced inhibitor of kappaB alpha (I&#x3ba;B&#x3b1;) degradation and nuclear factor of kappaB (NF-&#x3ba;B) activation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yu-Li</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yu-Chen</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Cheng-Chao</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shih-Yeh</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yu-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Hui-Ping</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Bor-Luen</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020672">I-kappa B Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606204">NFKBIA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495345">TLR4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>139874-52-5</RegistryNumber><NameOfSubstance UI="D000072000">NF-KappaB Inhibitor alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="Y">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004705" MajorTopicYN="N">Endocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020672" MajorTopicYN="N">I-kappa B Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056747" MajorTopicYN="N">Immunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072000" MajorTopicYN="N">NF-KappaB Inhibitor alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25360749</ArticleId><ArticleId IdType="pmc">PMC4216083</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0111496</ArticleId><ArticleId IdType="pii">PONE-D-14-12584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tagaya I, Takayama R, Hagiwara A (1981) A large-scale epidemic of hand, foot and mouth disease associated with enterovirus 71 infection in Japan in 1978. Jpn J Med Sci Biol 34: 191&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">6273621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, et al. (2008) Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis 198: 1002&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WH, Kuo TC, Lin YT, Huang SW, Liu HF, et al. (2013) Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012. PLoS One 8: e83711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3877097</ArticleId><ArticleId IdType="pubmed">24391812</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CN, Lin YC, Fann C, Liao NS, Shih SR, et al. (2001) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20: 895&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeltins A (2013) Construction and characterization of virus-like particles: a review. Mol Biotechnol 53: 92&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090963</ArticleId><ArticleId IdType="pubmed">23001867</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacher G, Kaeser MD, Moser C, Gurny R, Borchard G (2013) Recent advances in mucosal immunization using virus-like particles. Mol Pharm 10: 1596&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pubmed">23548071</ArticleId></ArticleIdList></Reference><Reference><Citation>Grgacic EV, Anderson DA (2006) Virus-like particles: passport to immune recognition. Methods 40: 60&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128828</ArticleId><ArticleId IdType="pubmed">16997714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Hsu JT, Huang JH, Ho MS, Ho YC (2003) Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett 25: 919&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pubmed">12889824</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, et al. (2006) Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 12: 921&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066158</ArticleId><ArticleId IdType="pubmed">16521221</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521319</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039784</ArticleId></ArticleIdList></Reference><Reference><Citation>Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, et al. (2007) CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37: 686&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">17301951</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">11861616</ArticleId></ArticleIdList></Reference><Reference><Citation>Korokhov N, Noureddini SC, Curiel DT, Santegoets SJ, Scheper RJ, et al. (2005) A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system. Mol Pharm 2: 218&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">15934782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ausiello CM, Fedele G, Urbani F, Lande R, Di Carlo B, et al. (2002) Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J Infect Dis 186: 351&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">12134231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, et al. (2012) Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 30: 1305&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pubmed">22214888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Liang YC, Tseng YS, Huang HY, Chou SY, et al. (2009) An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. J Leukoc Biol 86: 877&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">19498044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Wang SW, Tung YY, Chen SH (2009) Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood) 234: 1166&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Neil TK, Fearnley DB, McLellan AD, Vuckovic S, et al. (2000) Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol 12: 1511&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pubmed">11058570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou NT, Cheng CF, Wu HC, Lai CP, Lin LT, et al.. (2012) Chlorella sorokiniana-Induced Activation and Maturation of Human Monocyte-Derived Dendritic Cells through NF-kappa B and PI3K/MAPK Pathways. Evidence-Based Complementary and Alternative Medicine.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Petsch D, Deckwer WD, Anspach FB (1998) Proteinase K digestion of proteins improves detection of bacterial endotoxins by the Limulus amebocyte lysate assay: application for endotoxin removal from cationic proteins. Anal Biochem 259: 42&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">9606141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">9597130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramqvist T, Andreasson K, Dalianis T (2007) Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. Expert Opin Biol Ther 7: 997&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17665989</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarewski A (2010) HPV vaccine: Cervarix. Expert Opin Biol Ther 10: 477&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">20132062</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonaguro FM, Tornesello ML, Buonaguro L (2009) Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Rev Vaccines 8: 1379&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pubmed">19803760</ArticleId></ArticleIdList></Reference><Reference><Citation>Young KR, McBurney SP, Karkhanis LU, Ross TM (2006) Virus-like particles: designing an effective AIDS vaccine. Methods 40: 98&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">16997718</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, Sings HL, Bryan JT, Wang B, Wang Y, et al. (2007) GARDASIL: prophylactic human papillomavirus vaccine development&#x2013;from bench top to bed-side. Clin Pharmacol Ther 81: 259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">17259949</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, et al. (2008) Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26: 1855&#x2013;1862.</Citation><ArticleIdList><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinchieri G (1993) Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14: 335&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">8103338</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayette J, Durand I, Bridon JM, Arpin C, Dubois B, et al. (1998) Dendritic cells enhance the differentiation of naive B cells into plasma cells invitro. Scand J Immunol 48: 563&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">9874489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JG, Tong J, Liu HB, Liu YZ, Su ZL, et al. (2012) Increased frequency of Th17 cells in the peripheral blood of children infected with enterovirus 71. Journal of Medical Virology 84: 763&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">22431024</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald KPA, Munster DJ, Clark GJ, Dzionek A, Schmitz J, et al. (2002) Characterization of human blood dendritic cell subsets. Blood 100: 4512&#x2013;4520.</Citation><ArticleIdList><ArticleId IdType="pubmed">12393628</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreibelt G, Tel J, Sliepen KHEWJ, Benitez-Ribas D, Figdor CG, et al. (2010) Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunology Immunotherapy 59: 1573&#x2013;1582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11029854</ArticleId><ArticleId IdType="pubmed">20204387</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte BM, Kers-Rebel ED, Prosser AC, Galama JMD, van Kuppeveld FJM, et al.. (2013) Differential Susceptibility and Response of Primary Human Myeloid BDCA1(+) Dendritic Cells to Infection with Different Enteroviruses. Plos One 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634769</ArticleId><ArticleId IdType="pubmed">23638101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, et al. (2001) Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 166: 5346&#x2013;5355.</Citation><ArticleIdList><ArticleId IdType="pubmed">11313370</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M, Peng J, Jabbar IA, Liu X, Filgueira L, et al. (2005) Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta. Immunol Cell Biol 83: 83&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15661045</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva DM, Fausch SC, Verbeek JS, Kast WM (2007) Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity. J Immunol 178: 7587&#x2013;7597.</Citation><ArticleIdList><ArticleId IdType="pubmed">17548594</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll RC, O'Neill LA (2010) New insights into the regulation of signalling by toll-like receptors and nod-like receptors. J Innate Immun 2: 406&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">20505309</ArticleId></ArticleIdList></Reference><Reference><Citation>Duenas AI, Orduna A, Crespo MS, Garcia-Rodriguez C (2004) Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int Immunol 16: 1467&#x2013;1475.</Citation><ArticleIdList><ArticleId IdType="pubmed">15339879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Young DW, Gusovsky F, Chow JC (2000) Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275: 20861&#x2013;20866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10877845</ArticleId></ArticleIdList></Reference><Reference><Citation>Park BS, Song DH, Kim HM, Choi BS, Lee H, et al. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pubmed">19252480</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG (2012) Crystal structure of human enterovirus 71. Science 336: 1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren XX, Ma L, Liu QW, Li C, Huang Z, et al.. (2014) The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virology Journal 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3995660</ArticleId><ArticleId IdType="pubmed">24620896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, et al. (2009) Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15: 794&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, et al. (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15: 798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S (2011) Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 85: 4937&#x2013;4946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S (2013) Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71. Journal of Virology 87: 3335&#x2013;3347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto T, Kojima K, Funakoshi T, Endo Y, Fujita T, et al. (1996) Molecular cloning and characterization of murine IL-12 genes. J Immunol 156: 1082&#x2013;1088.</Citation><ArticleIdList><ArticleId IdType="pubmed">8557982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>